Carly Kenselaar

Stock Analyst at Citigroup

(2.84)

# 1,528

Out of 5,182 analysts

8

Total ratings

100%

Success rate

87.56%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$260.95	-32.55%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$30.44	+5.12%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $260.95

Upside: -32.55%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $30.44

Upside: +5.12%